AMETEK INC/

Listed Company

AMECIK 0001037868NYSELarge AcceleratedIndustrial Instruments For Measurement, Display, And ControlDelawareFY ends Dec 31

Period

FY 2025

Revenue

$7.40B

Net Income

$1.48B

Total Assets

$16.07B

Equity

$10.63B

Shares Out

229.20M

Op. Cash Flow

$1.80B

Business

AMETEK Inc. is a leading global manufacturer of electronic instruments and electromechanical devices serving industrial, aerospace, medical and power markets. It offers advanced analytical, test and measurement instruments, power and aerospace instrumentation, precision motion control solutions, medical components and devices, thermal management systems, specialty metals and electrical interconnects. The company operates through two reportable segments: Electronic Instruments (EIG) and Electromechanical (EMG), each comprising multiple niche product lines and services including MRO and inspection systems. AMETEK markets and sells worldwide across North America, Europe, Asia and South America via direct sales, distributors and specialized sales representatives.

Summary from filing dated 2025-02-20

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	7,401	6,941	6,597	6,151	—
Cost of sales	4,734	4,465	4,212	4,005	3,634
Selling, general and administrative	757	697	677	645	604
Total operating expenses	5,491	5,162	4,889	4,650	4,238
Operating income	1,910	1,780	1,707	1,501	1,309
Interest expense	−81	−113	−82	−83	—
Other (expense) income, net	−31	−5	−19	11	−5
Income before Income Taxes	1,798	1,662	1,606	1,429	1,223
Provision for income taxes	318	285	293	269	233
Net income	1,480	1,376	1,313	1,160	990
Basic earnings per share (in USD per share)	6.42	5.95	5.7	5.04	4.29
Diluted earnings per share (in USD per share)	6.4	5.93	5.67	5.01	4.25
Basic shares (in shares)	230	231	231	230	231
Diluted shares (in shares)	231	232	232	232	233

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	458	374	410	345	347
Receivables	1,119	949	1,013	919	829
Inventories, net	1,106	1,022	1,132	1,044	769
Other current assets	336	258	269	219	184
Total current assets	3,020	2,603	2,825	2,528	2,129
Property, plant and equipment, net	855	819	891	636	617
Right of use assets, net	273	236	230	170	170
Goodwill	7,171	6,556	6,448	5,373	5,239
Other intangibles, net	4,128	3,915	4,165	3,342	3,369
Investments and other assets	620	503	465	382	375
Total assets	16,068	14,631	15,024	12,431	11,898
Short-term borrowings and current portion of long-term debt, net	1,209	654	1,418	226	315
Accounts payable	618	523	517	497	470
Customer advanced payments	396	364	376	358	299
Income taxes payable	83	84	70	48	36
Accrued liabilities and other	537	473	503	435	443
Total current liabilities	2,843	2,099	2,883	1,564	1,563
Long-term debt, net	1,074	1,425	1,895	2,159	2,229
Deferred income taxes	789	831	837	694	720
Other long-term liabilities	733	621	679	537	514
Total liabilities	5,439	4,976	6,293	4,955	5,026
Preferred stock, $0.01 par value; authorized 5,000,000 shares; none issued	0	0	0	0	0
Common stock, $0.01 par value; authorized 800,000,000 shares; issued: 2025 270,471,745 shares; 2024 270,064,222 shares	3	3	3	3	3
Capital in excess of par value	1,317	1,265	1,169	1,094	1,013
Retained earnings	12,252	11,058	9,940	8,857	7,900
Accumulated other comprehensive loss	−399	−556	−485	−575	−470
Treasury stock: 2025 41,434,441 shares; 2024 39,364,801 shares	−2,545	−2,114	−1,897	−1,903	−1,573
Total stockholders equity	10,629	9,655	8,730	7,477	6,872
Total liabilities and stockholders equity	16,068	14,631	15,024	12,431	11,898

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net income	1,480	1,376	1,313	1,160	990
Depreciation and amortization	423	383	338	319	292
Deferred income taxes	−71	−13	−92	−68	−30
Share-based compensation expense	48	48	46	47	46
Gain on sale of facilities	−91,000	−995,000	−120,000	−7	0
(Increase) decrease in receivables	−55	53	8	−87	−173
(Increase) decrease in inventories and other current assets	−27	73	57	−322	−130
(Decrease) increase in payables, accruals and income taxes	−51	−18	10	95	212
Increase (decrease) in other long-term liabilities	73	−41	67	47	−35
Pension contributions	−8	−9	−9	−9	−10
Other, net	−9	−22	−4	−23	4
Total operating activities	1,802	1,829	1,735	1,149	1,160
Additions to property, plant and equipment	−130	−127	−136	−139	−111
Purchases of businesses, net of cash acquired	−933	−118	−2,238	−430	−1,959
Proceeds from sale of facilities	200,000	4	880,000	12	2
Other, net	520,000	−4	−3	471,000	−294,000
Total investing activities	−1,063	−245	−2,376	−553	−2,056
Net change in short-term borrowings	521	−890	892	−74	244
Repayments of long-term borrowings	−515	−300	0	0	−60
Repurchases of common stock	−434	−212	−8	−333	−15
Cash dividends paid	−285	−259	−230	−202	−185
Proceeds from stock option exercises	36	67	51	50	60
Other, net	−10	−9	−8	−17	−6
Total financing activities	−686	−1,602	697	−576	39
Effect of exchange rate changes on cash and cash equivalents	31	−17	8	−22	−10
Increase (decrease) in cash and cash equivalents	84	−36	64	−1	−866

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro